Hangzhou Diagens Biotechnology Co., Ltd.HKEX: 2526

VOLUNTARY ANNOUNCEMENT - GLOBAL LAUNCH OF THE UPGRADED iMedLoop PLATFORM AND OPENING OF API SUBSCRIPTION

· Issued by Hangzhou Diagens Biotechnology Co., Ltd. via HKEXnews

Filed with HKEX · Stock code 2526 · · 2 pages · English

Summary by 6ix AI

Hangzhou Diagens Biotechnology Co., Ltd. has announced the global launch of its upgraded iMedLoop platform and the opening of API subscriptions. The upgraded platform integrates advanced medical imaging capabilities and allows users to analyze imaging data without programming skills. This launch is seen as a significant step in expanding the company's business model and reaching international markets. The company aims to enhance health management through intelligent image interpretation services for a broader audience.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Hangzhou Diagens Biotechnology Co., Ltd. on 6ix

Earlier from Hangzhou Diagens Biotechnology

All Hangzhou Diagens Biotechnology news releases